Medicover AB (publ) carries a market capitalization of 30.72B, placing it among publicly traded companies globally. Its enterprise value stands at 4.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 30.72B |
| Enterprise Value | 4.73B |
Medicover AB (publ) currently has 150.98M shares outstanding.
| Shares Outstanding | 150.98M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Medicover AB (publ) trades at a trailing price-to-earnings ratio of 77.88. The price-to-sales ratio is 1.50, and the price-to-book ratio stands at 27.84.
| PE Ratio | 77.88 |
| PS Ratio | 1.50 |
| PB Ratio | 27.84 |
| P/TBV Ratio | -10.68 |
| P/FCF Ratio | 8.36 |
| P/OCF Ratio | 12.02 |
On an enterprise value basis, Medicover AB (publ) trades at an EV/EBITDA multiple of 43.94 and an EV/FCF ratio of 10.49. The EV/Sales ratio of 2.10 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 43.94 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.10 |
| EV / EBITDA | 43.94 |
| EV / EBIT | 43.94 |
| EV / FCF | 10.49 |
Medicover AB (publ) maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 293.55, indicating elevated leverage, while an interest coverage ratio of 1.68 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.87 |
| Quick Ratio | 0.16 |
| Debt / Equity | 293.55 |
| Debt / EBITDA | 13.22 |
| Interest Coverage | 1.68 |
Medicover AB (publ) posts a return on equity of 31.61 and a return on invested capital of 4.29.
| Return on Equity (ROE) | 31.61 |
| Return on Assets (ROA) | 1.99 |
| Return on Invested Capital (ROIC) | 4.29 |
| Return on Capital Employed (ROCE) | 6.52 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 28.02 |
Over the trailing twelve months, Medicover AB (publ) has paid 15.40M in income taxes, reflecting an effective tax rate of 28.31.
| Income Tax | 15.40M |
| Effective Tax Rate | 28.31 |
Medicover AB (publ)'s stock has declined approximately -15.38462% over the past 52 weeks. The 50-day moving average sits at 199.87, while the 200-day moving average is 223.33.
| Beta (5Y) | N/A |
| 52-Week Price Change | -15.38462% |
| 50-Day Moving Average | 199.87 |
| 200-Day Moving Average | 223.33 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Medicover AB (publ) generated 2.26B in revenue and converted that into 43.40M in net income, yielding earnings per share of 0.26. EBITDA reached 107.70M, while operating income came in at 107.70M.
| Revenue | 2.26B |
| Gross Profit | 508.60M |
| Operating Income | 107.70M |
| Pretax Income | 54.40M |
| Net Income | 43.40M |
| EBITDA | 107.70M |
| EBIT | 107.70M |
| Earnings Per Share (EPS) | 0.26 |
Medicover AB (publ) holds 89.40M in cash and equivalents against 1.42B in total debt, resulting in a net debt position of 820.00M. Total book value stands at 121.40M, with working capital of -68.70M providing operational flexibility.
| Cash & Cash Equivalents | 89.40M |
| Total Debt | 1.42B |
| Net Debt | 820.00M |
| Equity (Book Value) | 121.40M |
| Book Value Per Share | 0.81 |
| Working Capital | -68.70M |
Medicover AB (publ) produced 281.30M in operating cash flow over the past twelve months. After subtracting -124.00M in capital expenditures, free cash flow totaled 157.30M - equivalent to 1.05 per share.
| Operating Cash Flow | 281.30M |
| Capital Expenditures | -124.00M |
| Free Cash Flow | 157.30M |
| FCF Per Share | 1.05 |
Medicover AB (publ) operates with a gross margin of 22.52, reflecting its pricing power and cost economics. The operating margin of 4.77 and net profit margin of 1.92 provide insight into operational efficiency.
| Gross Margin | 22.52 |
| Operating Margin | 4.77 |
| Pretax Margin | 2.41 |
| Profit Margin | 1.92 |
| EBITDA Margin | 4.77 |
The company's payout ratio of 65.03 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.15 |
| Dividend Yield | N/A |
| Payout Ratio | 65.03 |
| Shareholder Yield | -0.43 |
| FCF Yield | 11.97 |
Medicover AB (publ) posts an Altman Z-Score of 2.86, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.86 |